Description
EXERCISE OPTION YEAR
Base award description: IGF::OT::IGF ONCOTYPE TESTING FOR CANCER
Modification chain · 16 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-10-01+$100,500= $100,500
- Mod P000012017-10-01+$383,985= $484,484
- Mod P000032018-02-28-$19,913= $464,571
- Mod P000042018-03-05-$74,720= $389,851
- Mod P000052018-03-27-$74,720= $315,130
- Mod P000062018-08-03-$74,720= $240,410
- Mod P000022018-08-29-$147,673= $92,737
- Mod P000092018-10-11+$26,752= $119,489
- Mod P00102018-10-11+$0= $119,489
- Mod P000072019-01-02-$33,017= $86,472
- Mod P000102019-02-26-$9,957= $76,515
- Mod P000112019-03-07-$9,957= $66,559
- Mod P000122019-03-13-$5,111= $61,447
- Mod P000132019-10-01+$9,957= $71,404
- Mod P000142020-07-02-$9,957= $61,447
- Mod P000152021-06-30-$9,957= $51,491
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-10-01 | +$100,500 | $100,500 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00001· EXERCISE AN OPTION | 2017-10-01 | +$383,985 | $484,484 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00003· FUNDING ONLY ACTION | 2018-02-28 | −$19,913 | $464,571 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00004· FUNDING ONLY ACTION | 2018-03-05 | −$74,720 | $389,851 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2018-03-27 | −$74,720 | $315,130 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00006· EXERCISE AN OPTION | 2018-08-03 | −$74,720 | $240,410 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00002· CHANGE ORDER | 2018-08-29 | −$147,673 | $92,737 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-10-11 | +$26,752 | $119,489 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P0010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-10-11 | +$0 | $119,489 | IGF::OT::IGF ONCOTYPE TESTING FOR CANCER |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-01-02 | −$33,017 | $86,472 | DE-OBLIGATE FUNDS FOR CLOSEOUT- ONCOTYPE TESTING FOR CANCER |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-02-26 | −$9,957 | $76,515 | DE-OBLIGATE FUNDS FOR CLOSEOUT- ONCOTYPE TESTING FOR CANCER |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-07 | −$9,957 | $66,559 | DE-OBLIGATE FUNDS FOR CLOSEOUT- ONCOTYPE TESTING FOR CANCER |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-13 | −$5,111 | $61,447 | DE-OBLIGATE FUNDS FOR CLOSEOUT- ONCOTYPE TESTING FOR CANCER |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-10-01 | +$9,957 | $71,404 | EXERCISE OPTION YEAR |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-07-02 | −$9,957 | $61,447 | EXERCISE OPTION YEAR |
| Mod P00015· FUNDING ONLY ACTION | 2021-06-30 | −$9,957 | $51,491 | EXERCISE OPTION YEAR |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RHN3L7SBF7J6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0377 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $55,912 | FY2026 |
| 36C26225N0452 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $114,305 | FY2025 |
| 36C26224N0385 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $114,305 | FY2024 |
| 36C26223P1608 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $10,362 | FY2023 |
| 36C26223N0393 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $194,070 | FY2023 |
| 36C26223A0031 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2023 |
Other recipients under Q301 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226D0089 | QUEST DIAGNOSTICS INCORPORATED | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $0 | FY2026 |
| 36C26226P1169 | MAYO COLLABORATIVE SERVICES, INC. | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $264,075 | FY2026 |
| 36C26226P1118 | TWIST BIOSCIENCE CORPORATION | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $47,450 | FY2026 |
| 36C26226P1103 | SONORA QUEST LABORATORIES LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $150,543 | FY2026 |
| 36C26226N0666 | TOSOH BIOSCIENCE, INC. | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $52,224 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25816C0136_3600_-NONE-_-NONE- · retrieved 2026-09-26.